Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term combination therapy of SMP-508 (repaglinide) with metformin in type 2 diabetes mellitus
jRCT2080221167Phase 3
- Sponsor
- Sumitomo Pharma
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of repaglinide in type 2 diabetes mellitus (T2DM), sponsored by Sumitomo Pharma.
02
Drugs
repaglinide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT2080221167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221167.